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Article type:Original article Objective(s): Breast cancer is the second leading cause of cancer death in females. Understanding molecular mechanisms in cancer cells compared with normal cells is crucial for diagnostic and 
therapeutic strategies. Long intergenic non-protein coding RNA, a regulator of reprogramming 
(lincRNA-RoR) is a noncoding RNA which initially was detected in induced pluripotent stem cells, and 
it has an important role in cell reprogramming and highly expressed in breast cancer cells. A key point 
in successful gene silencing is the usage of siRNA delivery system that is safe and efficient. 
Materials and Methods: In this study, the fifth-generation of PAMAM dendrimer is used as a nanocarrier 
for entering siRNA molecules for gene silencing of lincRNA-RoR. WDR7 is the gene encoding adjacent 
of lincRNA-RoR, which has an important role in apoptosis and cell cycle. Gel retardation assay was 
used to find the best Negative/Positive (N/P) molar charge ratio of siRNA- PAMAM transfected into 
MDA-MB 231 cells. MTT assay was performed 24 hr after transfection revealed the IC50 value (half 
maximal inhibitory concentrations) about 100 nanomolar for lincRNA-ROR siRNA.
Results: The lincRNA-RoR and WDR7 gene expression changes were evaluated by real-time PCR after 
siRNA treatment and showed an increase in the gene expression of WDR7. 
Conclusion: This study showed that PAMAM dendrimer G5/ siRNA could be a useful system delivery 
for future gene therapy approaches.
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Introduction
Cancer is one of the most important causes of death 
in the world, and breast cancer is the second cause of 
death (1). Ectopic and high expression of OCT4, SOX2, 
KLF4, and c-MYC could reprogram somatic differentiated 
cells to an embryonic-like or pluripotent state (2-5). 
Long non-coding RNAs (lncRNAs) have important 
roles in metabolism and functional regulatory in all 
cells, including normal and cancer cells (3, 6-10). The 
most important group of lncRNAs are long intergenic 
non-coding RNAs (lincRNAs), which play major roles 
in regulating various cell functions and development 
of different diseases, including stem cell state and 
cancer metastasis (11-13). LincRNA-RoRs are involved 
in diverse functions, including stem cell pluripotency, 
sponges of miRNA (14). Linc-RoR possesses a binding 
site for pluripotency transcription factors (TFs) Oct4, 
Sox2, and Nanog, which competing endogenous 
RNA (CeRNA) to regulate the expression of nuclear 
transcription factor (4). Ectopic and high expression of 
lincRNA-ROR are observed in various cancers, including 
breast, hepatocellular, endometrial (15-21).
Poly (amidoamine) (PAMAM) dendrimers are 
effective vectors for siRNA delivery (22-23). WDR7 gene 
encodes a member of the WD-repeat protein family. WD 
repeats are areas with the repetitions of approximately 
40 amino acids that have ends with trp-asp and gly-his 
amino acids (GH-WD) which may help to form a multi-
protein complex. WDR7 associates with rabconnectin 3 
A and interacts with DMXL2; It plays a role in V-ATPase 
function (24). WDR7 is located in 18q21.31 near the 
lincRNA-RoR (25).
For better understanding of regulatory effects 
of lincRNA-RoR in molecular biology and its role in 
cancer; they may lead to a novel cancer therapeutically 
approach. Which one of the combination of a long non 
coding RNA, siRNA and other gene therapies or chemical 
drugs are more efficient treatments than chemical 
therapies. Therefore, in this study focused on the effect 
of lincRNA-RoR silencing on gene expression level of the 
WDR7 gene. 
Materials and Methods
Polyamidoamine (PAMAM) dendrimers were 
supplied from Sigma Chemical Co (USA). Roswell Park 
Memorial Institute medium (RPMI) purchased from 
Biosera. Fetal bovine serum (FBS) was obtained from 
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Biosera. Antibiotics (10 000 units penicillin, 10 mg 
streptomycin) were supplied by (Sigma, St Louis, MO). 
The TriPure reagent was acquired from (SIGMA, USA). 
RNase-free DNase I was acquired from (Takara, Japan). 
Gel shift assays 
Gel Shift Assays of siRNA/ PAMAM dendrimer 
complexes were performed by 1.2 % agarose gel. Two 
microliters of the siRNAs aqueous solution (100 ng/
μL) with the desired amount of G5 PAMAM dendrimer 
solution were mixed gently and balanced at 37 °C for 30 
min to obtain various N/P ratios.
Cell culture 
The human MDA-MB-231 breast cancer cell line 
was cultured in RPMI 1640 medium (Thermo Fisher 
Scientific) supplemented with 10% FBS and penicillin–
streptomycin solution at 37 °C in a humidified 
atmosphere with 5% CO2. 
Transfection of siRNAs
Two different linc-RoR siRNA (50 to 30); siRNA 
linc-ROR-1: GGAGAGGAAGCCTGAGAGT, and siRNA linc-
ROR-2: GGTTAAAGACAC AGGGGAA as well as a non-
targeting (NT) control siRNA (siGENOME Non-Targeting 
siRNA) transfected into MDA-MB-231 cell line with 
PAMAM G5 dendrimer without FBS serum in the cell 
culture (23).
Cytotoxicity assays 
The effect of (siRNA-PAMAM dendrimers) dendriplex 
on the viability of MDA-MB-231 cells, was determined 
by using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay. MDA-MB-231 cells 
were seeded at 1×104 cells per well in a 96-well plate in 
a final volume of 200 µl/well at ~24 hr before the assay. 
Cells were exposed to different complexes of siRNA-
PAMAM dendrimers at various concentrations without 
FBS serum. At the end of the incubation time (24 hr), 
20 µl/well MTT reagent  added to each sample and the 
plates incubated for 5 hr at 37 °C in standard culture 
conditions. Finally, the absorbances measured at 490 nm 
using ELISA reader (Awareness Technology ChroMate® 
Microplate Reader). The estimated percentage of cell 
viability compared with the value of the untreated 
control cells.
Real-time PCR analysis
The total RNA was extracted from cells using Tripur 
(Roch) according to the manufacturer’s instruction. 
The RNA concentration was measured using Pico Drop 
A260/A280. To detect and compare gene expression, 
RNA was treated with RNase-free DNase I and cDNA 
was synthesized using Synthesis Kit (Takara). qRT-
PCR was accomplished by Cyber Green Real-Time PCR 
Takara kit in Applied Biosystem 7300 Fast System 
(ABI; Foster City, CA, USA). GAPDH was used as an 
internal control. The ΔΔCt method (2-ΔCt) were used to 
characterize the level of gene expressions. The following 
PCR primers were applied: lincRNA-ROR primers, 
forward: 5’-ACAAGGAGGAAAGGGCTGAC-3’, Revers: 
5’-TTCTGGAAGCTAAGTGCACATG-3’, and WDR7 primers, 
forward: 5’-AAAGTGGAGAGATGTGCCTCT-3’, reverse: 5’ 
AAA GCCTTCC TTCTCGCTGAT-3’.
Statistical analysis
Statistical analysis performed with GraphPad 
Prism 6 software. Results declared by mean±SD; 
One-way ANOVA and Student’s t-test used for statistical 
significance among study groups and P-values<0.05 
were considered statistically significant.
Results
Gel retardation of nano-siRNA complexes
The assembly of dendrimers-siRNA complex 
was confirmed by gel retardation. Anionic siRNA 
oligonucleotides was encapsulated after being mixed 
with polycationic nanocarriers; thus, inhibition of 
electrophoretic mobility of siRNA could be observed. In 
PAMAM-siRNA, band shift was blocked at an N/P ratio 
higher than 8. This result reveals that the best ratio of 
this complex is 10.
Cell survival
MTT assay was made on MDA-MB-231 cells which 
were incubated with various concentrations of the 
same composition. Relative cell viabilities in 24 hr were 
calculated (Figure 1) and revealed the half-maximal 
inhibitory concentrations (IC
50
 value) of lincRNA-ROR 
siRNA was about 100 nanomolar. (P<0.05).
Based on the cell toxicity result siRNA concentration 
of 100 nM was selected for further in vitro transfection 
experiments.
Gene expression analysis
Small interfering RNA (siRNA) for linc-RoR was 
schemed; afterward the effect on linc-RoR siRNA was 
evaluated by qPCR. LincRNA-RoR gene expression 
level in MDA-MB-231 cells decreased after RoR siRNA 
transfection by-PAMAM Dendrimers. According 
to outcomes, the lincRNA-RoR gene expression 
significantly down-regulated compared to the cells 
treated with scrambled siRNA, as control (P-value= 
0.02) (24 and 48 hr). The result represented an efficient 
siRNA transfection facilitated by PAMAM dendrimers 
and consequently, a successful gene silencing (Figure 2).
 
 
 
 
 
 
 
 
Figure 1. Cell toxicity assay of siRNA-PAMAM concentrations on 
MDA-MB-231 cancer cells. Three independent experiments have been 
performed with three replicates
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The overexpression of WDR7 after suppressing of 
lincRNA-RoR
WDR7 gene expression was compared with lincRNA-
RoR expression before and after the suppression of 
lincRNA-RoR. WDR7 and lincRNA-RoR gene expression 
level comparison in MDA-MB231 cells were not 
considered according to the formula 2 ^ - (Δct) and have 
been calculated based on a comparison of normalized 
gene expression levels (26). WDR7 normalized 
expression relative to normal expression of lincRNA-
RoR is low in the untreated cells (P-value = 0.0033), but 
after the suppression of lincRNA-RoR (24 and 48 hr), 
WDR7 expression was significantly increased (P-value 
= 0.002) (Figure 3).
Discussion
According to the literature review, this is first report 
of lincRNA- RoR gene silencing in the MDA-MB-231 
breast cancer cell line. lincRNA-RoR is a non-coding 
intergenic RNA, that was first obtained from stem cells. 
The non-coding RNA is involved in cancer through 
different mechanisms, including P53 pathways and 
reprogramming(17). It should be noted that according 
to Wang et al. lincRNA-RoR may regulate stem cell 
factors, including expression of Nanog, Oct4, and SOX2 
(4). Though cancer stem cell theory indicates the origin 
of a cancer stem cell reins the growth of cancer stem 
cells and potentially can prevent cancer (27-28). Note 
that the purpose of molecular interposition is to reduce 
the expression of these molecules and reverts to the 
lincRNA-RoR, which has a role in maintaining pluripotency 
property (4). Nagano and Fraser discussed about the strong 
response of lincRNA-RoR to OCT4 knockdown, and their role 
in reprogramming in fibroblasts. Knockdown of lincRNA-
RoR lead a significant decrease in induced pluripotent stem 
cells (iPSC) colony formation, which shows lincRNA-RoR 
plays a role in iPSC derivation (29). 
According to former researches, lincRNA-RoR 
overexpression in breast cancer is the cause of cancer 
progression, metastasis and tumor growth (17); But with 
our experience, this is first report of lincRNA- RoR gene 
silencing in MDA-MB-231 breast cancer cell line. 
Gene therapy in recent decades got more attention 
as a promising method to treat cancer and genetic 
disorders. RNAi is used for gene therapy and gene 
silencing, especially in research laboratories due to its 
high efficiency. Significant progress has been made in 
the field of siRNA nanoformulation, but still, there are no 
drugs on the market based on siRNA. An important issue 
is identifying safe and effective vectors to the successful 
delivery of siRNA and RNAi processes. Non-viral vectors 
also increasingly are proposed as alternatives to viral 
vectors, due to safety issues and the negative impact 
of viral methods for the delivery of siRNA (30). Non-
viral vectors are considered dendrimer-based siRNA 
vectors (31). In this study, amidoamine dendrimer 
(PAMAM) G5 was used as a delivery vehicle for siRNA 
molecules into the MDA-MB-231 cell line. For the first 
time, lincRNA- RoR gene silencing in breast cancer 
cell lines showed increased delivery efficiency of the 
siRNA with PAMAM dendrimers to breast cancer cell 
line MDA-MB-231. Real-time PCR indicates decreased 
expression of lncRNA-RoR in MDA-MB 231 cell line. 
The exact functions of lncRNA-RoR and WDR7 genes 
and their relative expressions in various cancers are 
not clear. However, it was demonstrated that the WD 
protein family has roles in various processes of the cell, 
including cell cycle progression, signal transduction, 
apoptosis, regulation of gene, and human diseases. 
Although understanding the molecular processes and 
exact functions of WD proteins is a big obstacle (32). It 
can be inferred that abnormal expression of WDR7 is 
involved in cancer. As is shown non-coding RNA of the 
human genome is involved in regulating the expression 
of other genes. On the other hand, the location of WDR7 
gene on chromosome 18 is near the lincRNA-RoR gene. 
Probably the positional effect of this gene is essential, 
 
 
 
. 
 
 
 
 
 
 
Figure 2. Changes in lincRNA-RoR gene expression at 24 and 48 hr 
after treatment with lincRNA-RoR siRNA
 
 Figure 3. Relative expression of WDR7. Gene expression levels of WDR7 
relative to the lincRNA-RoR. The comparison has been made before 
suppression 24 and 48 hr after the suppression of lincRNA-RoR expression
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and it can be explained that lncRNA adjacent to a gene 
with influencing on its expression has a regulatory 
effect (33). As mentioned earlier, the expression levels 
of linc-ROR and WDR7 genes are different. This study 
also indicates that the expressions of WDR7 and 
lincRNA-RoR in MDA-MB-231 breast cancer cell line 
are negatively related. In cell cycle and apoptosis, the 
expression of the lincRNA-RoR gene increases in breast 
cancer probably by reducing the expression of WDR7. 
Conclusion
This study illustrated that PAMAM dendrimer G5/ 
siRNA can be a useful system delivery for future gene 
therapy approaches. The application of generation 
five of PAMAM dendrimer was efficient to transfect 
lincRNA-RoR siRNA. Furthermore, this study showed 
that the expression of the wdr7 gene is influenced by 
the lincRNA-RoR, probably as a regulatory effect of long 
non coding RNA mechanisms. More future study about 
lincRNA-RoR molecular biology and its role in cancer 
may lead to a novel cancer therapeutically approach 
in which combination of lincRNA-RoR siRNA and other 
gene therapies or chemical drugs are more efficient 
treatments than conventional and prevalent chemical 
therapies.  
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